Bispecific Dual-Payload ADC: A Dual Upgrade in Antibody-Drug Conjugates — Three Companies Enter Clinical Stage
Jun 11, 2026 10:41
CST Updated
11:03
DAC Biotech
ADC Anti-Cancer Drug Developer
Innovent
High-end Biologics Developer
Alphamab Oncology
Developer of Antibody and Protein Macromolecule Drugs